[
1. Antunes, S., Rosa, C., Couto, J., Ferrolho, J., Domingos, A., 2017: Deciphering Babesia-vector interactions. Front. Cell. Infect. Microbiol., 7, 429. DOI: 10.3389/fcimb.2017.00429.
]Search in Google Scholar
[
2. Baneth, G., Nachum-Biala, Y., Birkenheuer, A. J., Schreeg, M. E., Prince, H., Florin-Christensen, M., et al., 2020: A new piroplasmid species infecting dogs: Morphological and molecular characterization and pathogeny of Babe-sia negevi n. sp. Parasit. Vectors., 13, 1, 130. DOI: 10.1186/s13071-020-3995-5.
]Search in Google Scholar
[
3. Barash, N. R., Thomas, B., Birkenheuer, A. J., Breitschwerdt, E. B., Lemler, E., Qurollo, B. A., 2019: Prevalence of Babesia spp. and clinical characteristics of Babesia vulpes infections in North American dogs. J. Vet. Intern. Med., 33, 5, 2075–2081. DOI: 10.1111/jvim.15560.
]Search in Google Scholar
[
4. Birkenheuer, A. J., Neel, J., Ruslander, D., Levy, M. G., Breitschwerdt, E. B., 2004: Detection and molecular characterization of a novel large Babesia species in a dog. Vet. Parasitol., 124, 3–4, 151–160. DOI: 10.1016/j.vetpar.2004.07.008.
]Search in Google Scholar
[
5. Cohn, L. A., Birkenheuer, A. J., Brunker, J. D., Ratcliff, E. R., Craig, A. W., 2011: Efficacy of atovaquone and azithromycin or imidocarb dipropionate in cats with acute cytauxzoonosis. J. Vet. Intern. Med., 25, 1, 55–60. DOI: 10.1111/j.1939-1676.2010.0646.x.
]Search in Google Scholar
[
6. Dear, J. D., Birkenheuer, A., 2022: Babesia in North America: An update. Vet. Clin. N. Am. Small Anim. Pract., 52, 6, 1193–1209. DOI: 10.1016/j.cvsm.2022.07.016.
]Search in Google Scholar
[
7. Djokic, V., Rocha, S. C., Parveen, N., 2021: Lessons learned for pathogenesis, immunology, and disease of erythrocytic parasites: Plasmodium and Babesia. Front. Cell. Infect. Microbiol., 11, 685239. DOI: 10.3389/fcimb.2021.685239.
]Search in Google Scholar
[
8. Elsworth, B., Duraisingh, M. T., 2021: A framework for signaling throughout the life cycle of Babesia species. Mol. Microbiol., 115, 5, 882–890. DOI: 10.1111/mmi.14650.
]Search in Google Scholar
[
9. Far, D., Takács, N., Gyurkovszky, M., Solymosi, N., Farkas, R., 2021: Ticks and tick-borne infections of dogs in two Jordanian shelters. Vector Borne Zoonotic Dis., 21, 8, 573–578. DOI: 10.1089/vbz.2021.0026.
]Search in Google Scholar
[
10. Gójska-Zygner, O., Zygner, W., 2015: Hyperaldosteronism and its association with hypotension and azotaemia in canine babesiosis. Vet. Q., 35, 1, 37–42. DOI: 10.1080/01652176.2014.981765.
]Search in Google Scholar
[
11. Guz, L., Ziętek, J., Puk, K., Adaszek, Ł., 2020: Inhibitory activities of essential oils against Babesia canis. Pol. J. Vet. Sci., 23, 1, 161–163. DOI: 10.24425/pjvs.2020.132761.
]Search in Google Scholar
[
12. Homer, M. J., Aguilar-Delfin, I., Telford, S. R., 3rd, Krause, P. J., Persing, D. H., 2000: Babesiosis. Clin. Microbiol. Rev., 13, 3, 451–469. DOI: 10.1128/CMR.13.3.451.
]Search in Google Scholar
[
13. Hwang, S. J., Yamasaki, M., Nakamura, K., Sasaki, N., Murakami, M., Wickramasekara Rajapakshage, B. K., et al., 2010: Development and characterization of a strain of Babesia gibsoni resistant to diminazene aceturate in vitro. J. Vet. Med. Sci., 72, 6, 765–771. DOI: 10.1292/jvms.09-0535.
]Search in Google Scholar
[
14. Checa, R., Montoya, A., Ortega, N., González-Fraga, J. L., Bartolomé, A., Gálvez, R., Marino, V., Miró, G., 2017: Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia micro-ti-like piroplasm. Parasit. Vect., 10, 1, 145. DOI: 10.1186/s13071-017-2049-0.
]Search in Google Scholar
[
15. Iguchi, A., Matsuu, A., Ikadai, H., Talukder, M. H., Hikasa, Y., 2012: Development of in vitro atovaquone-resistant Babesia gibsoni with a single-nucleotide polymorphism in cytb. Vet. Parasitol., 185, 2–4, 145–150. DOI: 10.1016/j. vetpar.2011.09.031.
]Search in Google Scholar
[
16. Javeed, N. N., Shultz, L., Barnum, S., Foley, J. E., Hodzic, E., Pascoe, E. L., et al., 2022: Prevalence and geographic distribution of Babesia conradae and detection of Babesia vogeli in free-ranging California coyotes (Canis latrans). Int. J. Parasitol. Parasites Wildl., 19, 294–300. DOI: 10.1016/j. ijppaw.2022.11.004.
]Search in Google Scholar
[
17. Ji, S., Rizk, M. A., Galon, E. M., El-Alfy, E. S., Mizukawa, Y., Kojima, M., et al., 2024: Anti-babesial activity of a series of 6,7-dimethoxyquinazoline-2,4-diamines (DMQDAs). Acta Trop., 249, 107069. DOI: 10.1016/j.actatropica.2023.107069.
]Search in Google Scholar
[
18. Kirk, S. K., Levy, J. K., Crawford, P. C., 2017: Efficacy of azithromycin and compounded atovaquone for treatment of Babesia gibsoni in dogs. J. Vet. Intern. Med., 31, 4, 1108–1112. DOI: 10.1111/jvim.14777.
]Search in Google Scholar
[
19. Köster, L. S., Lobetti, R. G., Kelly, P., 2015: Canine babe-siosis: A perspective on clinical complications, biomarkers, and treatment. Vet. Med. Res. Rep., 6, 119–128. DOI: 10.2147/VMRR.S60431.
]Search in Google Scholar
[
20. Kuleš, J., Bilić, P., Beer Ljubić, B., Gotić, J., Crnogaj, M., Brkljačić, M., Mrljak, V., 2018: Glomerular and tubular kidney damage markers in canine babesiosis caused by Babesia canis. Ticks. Tick-Borne Dis., 9, 6, 1508–1517. DOI: 10.1016/j.ttbdis.2018.07.012.
]Search in Google Scholar
[
21. Kuleš, J., de Torre-Minguela, C., Barić Rafaj, R., Gotić, J., Nižić, P., Ceron, J. J., Mrljak, V., 2016: Plasma biomarkers of SIRS and MODS associated with canine babesiosis. Res. Vet. Sci., 105, 222–228. DOI: 10.1016/j.rvsc.2016.02.011.
]Search in Google Scholar
[
22. Leisewitz, A. L., Mrljak, V., Dear, J. D., Birkenheuer, A., 2023: The diverse pathogenicity of various Babesia parasite species that infect dogs. Pathogens, 12, 1437. DOI: 10.3390/pathogens12121437.
]Search in Google Scholar
[
23. Li, H., Galon, E. M., Ji, S., Zafar, I., Ma, Z., Do, T., et al., 2023: In vitro screening of compounds from the Food and Drug Administration-approved library identifies anti-Babesia gibsoni activity of idarubicin hydrochloride and vorinostat. Parasitol. Int., 96, 102774. DOI: 10.1016/j.parint.2023.102774.
]Search in Google Scholar
[
24. Liberska, J., Michalik, J., Pers-Kamczyc, E., Wierzbicka, A., Lane, R. S., Rączka, G., et al., 2021: Prevalence of Babesia canis DNA in Ixodes ricinus ticks collected in forest and urban ecosystems in west-central Poland. Ticks. Tick-Borne Dis., 12, 5, 101786. DOI: 10.1016/j.ttbdis.2021.101786.
]Search in Google Scholar
[
25. Lin, E. C., Chueh, L. L., Lin, C. N., Hsieh, L. E., Su, B. L., 2012: The therapeutic efficacy of two antibabesial strategies against Babesia gibsoni. Vet. Parasitol., 186, 3–4, 159–164. DOI: 10.1016/j.vetpar.2011.11.073.
]Search in Google Scholar
[
26. Liu, M., Masatani, T., Adjou Moumouni, P. F., Lee, S. H., Galon, E. M., Gao, Y., et al., 2019: Inhibitory effects of the phytohormone inhibitors fluridone and inabenfide against Babesia gibsoni in vitro. Vet. Parasitol., 265, 19–23. DOI: 10.1016/j.vetpar.2018.11.018.
]Search in Google Scholar
[
27. Lobetti, R. G., Jacobson, L. S., 2001: Renal involvement in dogs with babesiosis. J. S. Afr. Vet. Assoc., 72, 1, 23–28. DOI: 10.4102/jsava.v72i1.604.
]Search in Google Scholar
[
28. Matijatko, V., Kis, I., Torti, M., Brkljacić, M., Kucer, N., Rafaj, R. B., et al., 2009: Septic shock in canine babesiosis. Vet. Parasitol., 162, 3–4, 263–270. DOI: 10.1016/j.vetpar.2009.03.011.
]Search in Google Scholar
[
29. Matsuu, A., Yamasaki, M., Xuan, X., Ikadai, H., Hikasa, Y., 2008: In vitro evaluation of the growth inhibitory activities of 15 drugs against Babesia gibsoni (Aomori strain). Vet. Parasitol., 157, 1–2, 1–8. DOI: 10.1016/j.vetpar.2008.07.023.
]Search in Google Scholar
[
30. Miller, D. M., Swan, G. E., Lobetti, R. G., Jacobson, L. S., 2005: The pharmacokinetics of diminazene aceturate after intramuscular administration in healthy dogs. J. S. Afr. Vet. Assoc., 76, 3, 146–150. DOI: 10.4102/jsava.v76i3.416.
]Search in Google Scholar
[
31. Plumb, D. C., 2015: Plumb’s Veterinary Drug Handbook, 8th edn., Wiley-Blackwell, Ames, 1296 pp.
]Search in Google Scholar
[
32. Rizk, M. A., El-Sayed, S. A. E., Igarashi, I., 2023: Diminazene aceturate and imidocarb dipropionate-based combination therapy for babesiosis – A new paradigm. Ticks. Tick-Borne Dis., 14, 4, 102145. DOI: 10.1016/j.ttbdis.2023.102145.
]Search in Google Scholar
[
33. Salant, H., Nachum-Biala, Y., Zivotofsky, D., Tzur, T. E., Baneth, G., 2024: Babesia negevi infection in dogs and response to treatment. Ticks. Tick-Borne Dis., 15, 1, 102282. DOI: 10.1016/j.ttbdis.2023.102282.
]Search in Google Scholar
[
34. Shabangu, N., Penzhorn, B. L., Oosthuizen, M. C., Vorster, I., van Schalkwyk, O. L., Harrison-White, R. F., Matjila, P. T., 2021: A shared pathogen: Babesia rossi in domestic dogs, black-backed jackals (Canis mesomelas) and African wild dogs (Lycaon pictus) in South Africa. Vet. Parasitol., 291, 109381. DOI: 10.1016/j.vetpar.2021.109381.
]Search in Google Scholar
[
35. Silaghi, C., Woll, D., Hamel, D., Pfister, K., Mahling, M., Pfeffer, M., 2012: Babesia spp. and Anaplasma phagocytophilum in questing ticks, ticks parasitizing rodents and the parasitized rodents – Analyzing the host-pathogen-vector interface in a metropolitan area. Parasit. Vectors., 5, 191. DOI: 10.1186/1756-3305-5-191.
]Search in Google Scholar
[
36. Solano-Gallego, L., Sainz, Á., Roura, X., Estrada-Peña, A., Miró, G., 2016: A review of canine babesiosis: The European perspective. Parasit. Vectors., 9, 1, 336. DOI: 10.1186/s13071-016-1596-0.
]Search in Google Scholar
[
37. Sudhakara Reddy, B., Sivajothi, S., Varaprasad Reddy, L. S., Solmon Raju, K. G., 2016: Clinical and laboratory findings of Babesia infection in dogs. J. Parasit. Dis., 40, 2, 268–272. DOI: 10.1007/s12639-014-0491-x.
]Search in Google Scholar
[
38. Wang, Y., Zhang, S., Wang, J., Rashid, M., Wang, X., Liu, X., Yin, H., Guan, G., 2022: Nested qPCR assay to detect Babesia duncani infection in hamsters and humans. Parasitol. Res., 121, 12, 3603–3610. DOI: 10.1007/s00436-022-07685-3.
]Search in Google Scholar
[
39. Yabsley, M. J., Shock, B. C., 2013: Natural history of zoonotic Babesia: Role of wildlife reservoirs. Int. J. Parasitol. Parasit. Wild., 2, 18–31. DOI: 10.1016/j.ijppaw.2012.11.003.
]Search in Google Scholar
[
40. Yamasaki, M., Watanabe, N., Idaka, N., Yamamori, T., Otsuguro, K., Uchida, N., et al., 2017: Intracellular diminazene aceturate content and adenosine incorporation in diminazene aceturate-resistant Babesia gibsoni isolate in vitro. Exp. Parasitol., 183, 92–98. DOI: 10.1016/j.exppara.2017.10.016.
]Search in Google Scholar
[
41. Zhang, Y., Bai, C., Shi, W., Alvarez-Manzo, H., Zhang, Y., 2020: Identification of essential oils including garlic oil and black pepper oil with high activity against Babesia duncani. Pathogens, 9, 6, 466. DOI: 10.3390/pathogens9060466.
]Search in Google Scholar
[
42. Zhao, L., Jiang, R., Jia, N., Ning, N., Zheng, Y., Huo, Q., et al., 2020: Human case infected with Babesia venatorum: A 5-year follow-up study. Open Forum Infect. Dis., 7, 3, ofaa062. DOI: 10.1093/ofid/ofaa062.
]Search in Google Scholar
[
43. Zygner, W., Gójska-Zygner, O., Bartosik, J., Górski, P., Karabowicz, J., Kotomski, G., Norbury, L. J., 2023: Canine babesiosis caused by large Babesia species: Global prevalence and risk factors – A review. Animals, 13, 16, 2612. DOI: 10.3390/ani13162612.
]Search in Google Scholar
[
44. Zygner, W., Gójska-Zygner, O., Norbury, L. J., 2023: Pathogenesis of anemia in canine babesiosis: Possible contribution of pro-inflammatory cytokines and chemokines – A review. Pathogens, 12, 2, 166. DOI: 10.3390/pathogens12020166.
]Search in Google Scholar
[
45. Zygner, W., Rodo, A., Gójska-Zygner, O., Górski, P., Bartosik, J., Kotomski, G., 2021: Disorders in blood circulation as a probable cause of death in dogs infected with Babe-sia canis. J. Vet. Res., 65, 3, 277–285. DOI: 10.2478/jvetres-2021-0036.
]Search in Google Scholar
